Solstice Advanced Materials Posts $1.05 Billion Q3 Sales, Raises 2026 Guidance

Solstice Advanced Materials reported Q3 2026 sales of $1.05B, up 8% YoY, with net income of $80M. Adjusted EPS was $0.80, and EBITDA rose 13% to $265M. The company raised its 2026 guidance for sales, EBITDA, and EPS. Growth was driven by electronic materials, refrigerants, and nuclear services. Solstice plans to complete a $500M share buyback by Q1 2027.

Original reporting
Published Nov 4, 2026, 11:13 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 11:20 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Solstice Advanced Materials Posts $1.05 Billion Q3 Sales, Raises 2026 Guidance — source image
Decision brief

The 30-second read

$SOLSBullishHigh
01

Why it matters

The raised guidance signals stronger demand across multiple end‑markets, likely supporting a price rally.

02

Market read

First‑report earnings and guidance raise for a mid‑cap industrial firm; material impact on its share price.

03

What to watch

Potential supply‑chain constraints in AI‑related sputtering targets could temper growth.

Relevance 8/10Novelty 8/10Timing: post‑market release

Background

Solstice Advanced Materials is a specialty materials supplier serving AI, data‑center, automotive and nuclear markets.

Company-level read

Ticker impact

$SOLSBullishHigh confidence
Context

Solstice Advanced Materials reported Q3 2026 sales of $1.046 B and raised full‑year guidance for sales, EBITDA and EPS.

Expected impact

likely upside as market prices in higher sales and earnings expectations

Evidence & confidence

Revenue and EBITDA guidance were increased by several hundred million dollars, a material improvement for a mid‑cap issuer.

Market effects

Boosts outlook for electronic materials and thermal management segments.

Positive for U.S. specialty materials sector.

Limited to niche industrial materials markets.

Counterpoint

If guidance is overly optimistic, the stock could face a pull‑back on subsequent earnings.

Key entities

  • Solstice Advanced Materials Inc.

    Specialty materials producer (ticker SOLS).

Related articles

$CMEMed

CME Nears Uranium Storage Deal for Physical Futures Contract

CME Group is nearing a deal with ConverDyn (a joint venture between Solstice Advanced Materials and General Atomics) to store uranium for a physical futures contract. The deal, expected to close by year-end, would involve Solstice managing inventories at its Illinois facility. This follows rising uranium demand and prices, with the spot price up over 10% this year.

$SOLSMed

Solstice Advanced Materials Inc (SOLS) (Q3 2026) Earnings Call Highlights: Record

Solstice Advanced Materials (SOLS) reported Q3 2026 net sales of $1.05B, up 8% YoY, exceeding guidance. Adjusted EBITDA rose 13% to $265M. Electronic materials sales surged 31%, while nuclear backlog grew to $2.6B. The company raised full-year guidance and plans to complete $500M in share repurchases by Q1 2027. Challenges include declines in building solutions and nuclear sales, capacity constraints, and terminated M&A plans.

$SOLSHighAI 8/10

What Solstice Advanced Mat (SOLS) Said on Its Q3 Earnings Call

Solstice Advanced Materials (SOLS) reported Q3 sales of $726M, up 6% YoY, with adjusted EBITDA rising 3% to $251M. Refrigerant sales increased 8%, offsetting residential market weakness. Nuclear backlog reached $2.6B. The company raised its full-year sales and EPS guidance, plans to complete share buybacks by Q1 2027, and is evaluating expansion projects.

$SOLSMedAI 8/10

Solstice Adv. Materials (SOLS) Q3 2026 Earnings Call Transcript

Solstice Adv. Materials (SOLS) reported Q3 2026 net sales of $1.05B, up 8% YoY, and raised full-year guidance. The company completed $100M in share repurchases and plans to finish the remaining $400M by Q1 2027. It highlighted growth in data center and nuclear conversion businesses, with a $2.6B nuclear backlog. Adjusted EBITDA rose 13% to $265M, and adjusted EPS was $0.80.